JAZZ
Jazz Pharmaceuticals PLC
231.40$
-2.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.6% | 16.5% | 29.6% | 32.4% | 37.8% | 36.6% | 47.9% | 8.5% | 42.1% | 30.3% | 38.2% | 34.4% | 36.1% | |
| 16.7% | 15.7% | 18.1% | 15.9% | 15.7% | 15.5% | 18.4% | 16.6% | 15.8% | 42.1% | 17.0% | 14.8% | 22.7% | |
| 5.8% | 5.2% | 6.8% | 5.5% | 5.7% | 6.5% | 7.5% | 6.2% | 7.8% | 16.7% | 7.0% | 6.1% | 9.5% | |
| 2.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.5% | -17.9% | 6.3% | -2.6% | -2.5% | -7.3% | 32.1% | -31.3% | 11.6% | -6.1% | -1.1% | -7.8% | -1.1% | |
| 0.4% | 1.0% | 0.8% | 0.7% | 1.0% | 1.2% | 4.3% | 1.2% | 1.3% | 5.5% | 1.8% | 1.5% | 2.6% | |
| -17.9% | – | -30.1% | -25.1% | 20.3% | -17.8% | -18.8% | -61.3% | -29.1% | -31.1% | 11.5% | 29.4% | -4.8% | |
| 0.6% | – | 12.4% | – | – | – | – | – | – | – | – | – | – | |
| -7.7% | -9.9% | -11.1% | -15.8% | -14.2% | 33.1% | – | -12.0% | 0.0% | 0.0% | – | – | – | |
| -0.8% | – | – | – | 37.7% | -0.7% | -84.4% | -0.7% | -0.7% | -0.6% | -0.7% | -83.4% | -22.4% | |
| -8.1% | -9.9% | -6.3% | -15.7% | 23.4% | -0.8% | -90.6% | -11.9% | -1.0% | 6.3% | -7.3% | -82.3% | -21.9% | |
| 5.5% | 17.8% | 3.0% | 6.1% | 81.7% | 21.6% | -61.4% | -64.3% | 4.1% | 6.3% | 42.3% | -18.6% | 7.6% | |
| 31.2% | 15.5% | 28.9% | 31.7% | 36.8% | 35.4% | 43.5% | 9.6% | 40.8% | 24.8% | 36.3% | 32.9% | 33.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.